Abstract
In this issue of Immunity, Nagashima etal., Wallrapp etal., and Xu etal. demonstrate that the neuropeptide calcitonin gene-related peptide (CGRP) fine tunes type 2 innate immune response via suppressing group 2 innate lymphoid cells (ILC2s).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have